Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Ugeskrift for Laeger|June 30, 2011
[Amoxicillin-induced hepatitis]Jakob Oxlund, Alan Hamilton Ferguson
Plant Diversity|August 31, 2018
Botanical aspects of eco-civilisation constructionAlan Hamilton, Shengji Pei, Lixin Yang
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|July 18, 2025
A Meta-Synthesis of Qualitative Literature to Inform the Selection of Meaningful and Measurable Health Concepts for Clinical Trials in COPDAshley Duenas, Klaudia Kornalksa, Alan Hamilton
Ugeskrift for Laeger|February 21, 2015
[Severe bradycardia in general anaesthesia in a patient treated with cholinesterase inhibitors for dementia]Marlene Ersgaard Jellinge, Alan Hamilton Ferguson
Journal of Telemedicine and Telecare|November 13, 2013
A pilot trial of emergency telemedicine in regional Western AustraliaGarth Herrington, Yvonne Zardins, Alan Hamilton
International Journal of Chronic Obstructive Pulmonary Disease|September 13, 2012
Assessing patient report of function: content validity of the Functional Performance Inventory-Short Form (FPI-SF) in patients with chronic obstructive pulmonary disease (COPD)Nancy Kline Leidy, Alan Hamilton, Karin Becker
Pharmaceutical Statistics|May 20, 2021
The detailed clinical objectives approach to designing clinical trials and choosing estimandsJames Bell, Alan Hamilton, Oliver Sailer, et al.
Advances in Therapy|March 8, 2019
Dose Determination for a Fixed-Dose Drug Combination: A Phase II Randomized Controlled Trial for Tiotropium/Olodaterol Versus Tiotropium in Patients with COPDFrançois Maltais, Alan Hamilton, Florian Voß, et al.
Therapeutic Advances in Respiratory Disease|June 3, 2020
Comparative measurement properties of constant work rate cycling and the endurance shuttle walking test in COPD: the TORRACTO® clinical trialFrançois Maltais, Denis E O'Donnell, Alan Hamilton, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 13, 2014
Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterolNeil S Roskell, Antonio Anzueto, Alan Hamilton, et al.
Pageof 5